Sundrug Statistics

Total Valuation

Sundrug has a market cap or net worth of JPY 492.32 billion. The enterprise value is 465.73 billion.

Market Cap	492.32B
Enterprise Value	465.73B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Sundrug has 116.97 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	n/a
Shares Outstanding	116.97M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	4.59%
Owned by Institutions (%)	27.83%
Float	67.02M

Valuation Ratios

The trailing PE ratio is 16.31 and the forward PE ratio is 15.39. Sundrug's PEG ratio is 3.14.

PE Ratio	16.31
Forward PE	15.39
PS Ratio	0.62
PB Ratio	1.87
P/TBV Ratio	1.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	3.14

Financial Ratio History

Enterprise Valuation

EV / Earnings	15.43
EV / Sales	0.59
EV / EBITDA	7.91
EV / EBIT	11.24
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.13.

Current Ratio	1.65
Quick Ratio	0.70
Debt / Equity	0.13
Debt / EBITDA	0.56
Debt / FCF	n/a
Interest Coverage	377.00

Financial Efficiency

Return on equity (ROE) is 11.85% and return on invested capital (ROIC) is 9.81%.

Return on Equity (ROE)	11.85%
Return on Assets (ROA)	6.57%
Return on Invested Capital (ROIC)	9.81%
Return on Capital Employed (ROCE)	13.98%
Revenue Per Employee	118.49M
Profits Per Employee	4.53M
Employee Count	6,662
Asset Turnover	1.95
Inventory Turnover	6.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.31% in the last 52 weeks. The beta is 0.22, so Sundrug's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-11.31%
50-Day Moving Average	4,172.44
200-Day Moving Average	4,024.01
Relative Strength Index (RSI)	54.58
Average Volume (20 Days)	393,530

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sundrug had revenue of JPY 789.40 billion and earned 30.18 billion in profits. Earnings per share was 258.00.

Revenue	789.40B
Gross Profit	200.25B
Operating Income	42.60B
Pretax Income	41.93B
Net Income	30.18B
EBITDA	60.02B
EBIT	42.60B
Earnings Per Share (EPS)	258.00

Full Income Statement

Balance Sheet

The company has 60.13 billion in cash and 33.54 billion in debt, giving a net cash position of 26.59 billion or 227.29 per share.

Cash & Cash Equivalents	60.13B
Total Debt	33.54B
Net Cash	26.59B
Net Cash Per Share	227.29
Equity (Book Value)	262.75B
Book Value Per Share	2,246.33
Working Capital	83.71B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 25.37%, with operating and profit margins of 5.40% and 3.82%.

Gross Margin	25.37%
Operating Margin	5.40%
Pretax Margin	5.31%
Profit Margin	3.82%
EBITDA Margin	7.60%
EBIT Margin	5.40%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 130.00, which amounts to a dividend yield of 3.07%.

Dividend Per Share	130.00
Dividend Yield	3.07%
Dividend Growth (YoY)	14.04%
Years of Dividend Growth	6
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	3.05%
Earnings Yield	6.13%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.

Last Split Date	Mar 29, 2017
Split Type	Forward
Split Ratio	2

Scores

Sundrug has an Altman Z-Score of 4.92.

Altman Z-Score	4.92
Piotroski F-Score	n/a